Markets · Live
DJIA50,687.07▼ -1.21%S&P 5007,553.68▼ -0.74%Nasdaq26,853.98▼ -0.89%DJIA50,687.07▼ -1.21%S&P 5007,553.68▼ -0.74%Nasdaq26,853.98▼ -0.89%
Friday, July 10, 2026 · ET
SubscribeMember LoginAdvertiseSubmit Article Search
New York--:--
Chicago--:--
Denver--:--
Los Angeles--:--
Honolulu--:--
Anchorage--:--
Tokyo--:--
Berlin--:--
London--:--
UTC--:--

Valor & Ventures MediaNews Edition

Executive news, veteran stories, leadership insight, business intelligence, and legacy-driven reporting.

● Breaking
◆BREAKING — Pentagon expands SkillBridge to 14 new corporate partners◆MARKETS — Defense-tech IPOs surge 22% YTD as veteran-led firms list◆AI & TECH — Veteran-founded startup unveils battlefield-grade edge AI◆VETREPRENEURS — SBA reports record veteran small-business loan approvals◆HEALTH — VA pilots equine therapy expansion across 9 states◆HOLLYWOOD — Three veteran-led films headline 2026 awards season◆LEADERSHIP — Fortune 500 CEOs cite military service in succession plans◆BREAKING — Pentagon expands SkillBridge to 14 new corporate partners◆MARKETS — Defense-tech IPOs surge 22% YTD as veteran-led firms list◆AI & TECH — Veteran-founded startup unveils battlefield-grade edge AI◆VETREPRENEURS — SBA reports record veteran small-business loan approvals◆HEALTH — VA pilots equine therapy expansion across 9 states◆HOLLYWOOD — Three veteran-led films headline 2026 awards season◆LEADERSHIP — Fortune 500 CEOs cite military service in succession plans
STAT News

STAT+: FDA finalists under review

Three top contenders to run the FDA are under review by the White House

John Wilkerson · 2 min read
By John Wilkerson· STAT News· Published · Photo: Alex Hogan/STAT· Edited by luke
Read the original at STAT News ↗

Reproduced under fair-use excerpt. Read the full article at the source link.

STAT+: FDA finalists under review
PHOTO: STAT NEWS

Full report available at the original source below.

Source & Credit

Reporting and photography credited as noted above. Originally published by STAT News.

Read full report at STAT News →
← Back to the deskAll VVM News